Discover trends, market shifts, and competitive outlooks for the mrna therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The mRNA Therapeutics Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for mRNA therapeutics has been on an upward trend in the last few years. The industry size is projected to increase from $34.76 billion in 2024 to $36.25 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.3%. The historical growth can be traced back to factors such as enhanced financial backing for the development of effective drugs and vaccines, the growth of government initiatives aimed at promoting RNA-centric medicines, increased understanding of rare genetic disorders, and a surge in clinical trials.

The market size of mRNA therapeutics is anticipated to experience consistent growth in the upcoming years, expanding to a whopping $42.23 billion by the year 2029, with a compound annual growth rate (CAGR) of 3.9%. The projected growth during the forecasted timeframe is mainly attributable to factors such as rising prevalence of infectious diseases, surge in patients seeking medical attention in hospitals and clinics, widening usage of mRNA therapeutics, escalating demand for precision and personalized medicine, conducive regulatory settings, and fast-tracked approval processes. Key trends foreseen during the forecasted period are the progression in mRNA delivery technologies, swift development and adoption of mRNA vaccines, the advent of self-replicating mRNA (saRNA) platforms, the ability of mRNA manufacturing to scale and adapt, and the innovation of new mRNA modifications.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the mRNA Therapeutics Market?

The escalation of persistent and transmittable diseases is estimated to drive the progression of the mRNA therapeutics market. Persistent and transmittable diseases, which include tuberculosis, HIV/AIDS, and hepatitis, are chronic illnesses that can be passed from person to person. The increasing occurrence of these diseases is attributed to increased global travel and subpar healthcare infrastructure, leading to their proliferation and obstructing their effective control. mRNA therapeutics assist in treating persistent and communicable diseases by enabling the body to promptly generate proteins to enhance immune responses, promoting faster development of treatments and vaccines. For example, GOV.UK reported in October 2023 that in 2022, 94,397 individuals in England were diagnosed with HIV and under medical care, marking a 3% increase from the 91,368 cases in 2021. As a result, the escalating occurrence of persistent and transmittable diseases is catalyzing the expansion of the mRNA therapeutics market.

Which Primary Segments of the mRNA Therapeutics Market Are Driving Growth and Industry Transformations?

The mRNA therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp

What Are the Fastest-Growing Geographies in the mRNA Therapeutics Market?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the mRNA Therapeutics Industry?

Major corporations in the mRNA therapeutics industry are prioritizing the creation of novel solutions, like mRNA-based booster vaccines, to reinforce immunity against changing virus variants. A booster vaccine based on messenger RNA (mRNA) is designed to enhance and extend immunity to a specific pathogen, typically following the primary series of vaccinations. For instance, Gennova Biopharmaceuticals Ltd., a pharmaceutical business based in India, introduced GEMCOVAC-OM, India’s first homegrown mRNA-based Omicron-tailored booster vaccine, in June 2023. The aim was to generate a vaccine that could trigger the required immune response against the SARS-CoV-2’s Omicron variant. Remarkably, GEMCOVAC-OM is thermostable, circumvents the necessity for ultra-cold chain infrastructure, and can be given with a needle-less device system, rendering it suitable for end-line deployment in India. In clinical trials, this vaccine yielded substantially greater immune responses than other vaccines, pointing to the importance of variant-focused vaccines in achieving intended immune responses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

What Parameters Are Used to Define the mRNA Therapeutics Market?

Messenger RNA (mRNA) therapeutics refers to a type of medical treatment that utilizes messenger RNA (mRNA) molecules to produce therapeutic proteins within the body. These therapeutics are used to prevent, treat, or cure diseases by directing cells to produce specific proteins that are needed for therapeutic effects.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model